To access this element change to forms mode OFF
Grant Award View - GA82108
Molecular Clamp Stabilized Spike Vaccine for Rapid Response
GA ID:
GA82108
Agency:
Department of Health and Aged Care
Approval Date:
7-Apr-2020
Publish Date:
11-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2021
Value (AUD):
$1,965,398.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_Novel_Coronavirus_Vaccine_Development_2020
Grant Activity:
Molecular Clamp Stabilized Spike Vaccine for Rapid Response
Purpose:
The Molecular Clamp platform is Australia’s most advanced COVID-19 vaccine program. The strategic partners leading this program are aiming to validate safety and efficacy to support development and scale-up of the vaccine for further clinical and potential emergency distribution. The proposed work will identify correlates of protection from infected patients and compare with immune responses elicited by the candidate vaccine. This information will support vaccine dose and adjuvant selection.
GO ID:
GO Title:
MRFF – EPCDR Initiative – 2020 Novel Coronavirus Vaccine Development Grant Opportunity
InternalReferenceId:
MRF1202445
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA